296 related articles for article (PubMed ID: 21959070)
1. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Kriplani A; Awasthi D; Kulshrestha V; Agarwal N
Int J Gynaecol Obstet; 2012 Jan; 116(1):35-8. PubMed ID: 21959070
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Senol T; Kahramanoglu I; Dogan Y; Baktiroglu M; Karateke A; Suer N
Clin Exp Obstet Gynecol; 2015; 42(2):224-7. PubMed ID: 26054124
[TBL] [Abstract][Full Text] [Related]
3. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
4. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
6. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
[TBL] [Abstract][Full Text] [Related]
7. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Reid PC; Virtanen-Kari S
BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
[TBL] [Abstract][Full Text] [Related]
11. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
12. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Mercorio F; De Simone R; Di Spiezio Sardo A; Cerrota G; Bifulco G; Vanacore F; Nappi C
Contraception; 2003 Apr; 67(4):277-80. PubMed ID: 12684148
[TBL] [Abstract][Full Text] [Related]
13. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
[TBL] [Abstract][Full Text] [Related]
15. Progestin-releasing intrauterine systems and leiomyoma.
Kaunitz AM
Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
Kriplani A; Singh BM; Lal S; Agarwal N
Int J Gynaecol Obstet; 2007 Jun; 97(3):190-4. PubMed ID: 17382331
[TBL] [Abstract][Full Text] [Related]
19. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
[TBL] [Abstract][Full Text] [Related]
20. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
